Bortezomib Injection falls in the class of medications that are known as antineoplastic agent. A solution liquid this is injected into the veins of the patients. This kills the cancer cells in the patients who are affected by multiple myeloma (a type of cancer of the bone marrow) and mantle cell lymphoma (a fast-growing cancer that begins in the cells of the immune system).
Used for Treatment:
Developed and Managed by Infocom Network Private Limited.